구조 |
화학 이름 |
CAS |
MF |
![1H-Imidazol-5-amine,1-methyl-4-nitro-(9CI)](/CAS/20180808/GIF/4531-54-8.gif) |
1H-Imidazol-5-amine,1-methyl-4-nitro-(9CI) |
4531-54-8 |
C4H6N4O2 |
![Tioconazole Related Compound A (25 mg) (1-[2,4-Dichloro-beta-[(3-thenyl)-oxy]phenethyl]imidazole hydrochloride)](/CAS/20180808/GIF/61709-33-9.gif) |
Tioconazole Related Compound A (25 mg) (1-[2,4-Dichloro-beta-[(3-thenyl)-oxy]phenethyl]imidazole hydrochloride) |
61709-33-9 |
C16H15Cl3N2OS |
![Desfluoro Risperidone](/CAS/GIF/106266-09-5.gif) |
Desfluoro Risperidone |
106266-09-5 |
C23H28N4O2 |
![GLIMEPIRIDE RELATED COMPOUND C (20 MG) (GLIMEPIRIDE URETHANE)](/CAS/20150408/GIF/119018-30-3.gif) |
GLIMEPIRIDE RELATED COMPOUND C (20 MG) (GLIMEPIRIDE URETHANE) |
119018-30-3 |
C18H23N3O6S |
![1-[(2S)-3-BroMo-2-Methyl-1-oxopropyl]-L-proline](/CAS/GIF/80629-35-2.gif) |
1-[(2S)-3-BroMo-2-Methyl-1-oxopropyl]-L-proline |
80629-35-2 |
C9H14BrNO3 |
![METHYL 6-CHLORO-1H-BENZO[D]IMIDAZOL-2-YLCARBAMATE](/CAS/GIF/20367-38-8.gif) |
METHYL 6-CHLORO-1H-BENZO[D]IMIDAZOL-2-YLCARBAMATE |
20367-38-8 |
C9H8ClN3O2 |
![Citalopram Related Compound B](/CAS/20180808/GIF/1332724-03-4.gif) |
Citalopram Related Compound B |
1332724-03-4 |
C22H23FN2O6 |
![6alpha-fluoro-11beta,21-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 21-pivalate](/CAS/GIF/29205-06-9.gif) |
6alpha-fluoro-11beta,21-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 21-pivalate |
29205-06-9 |
C27H37FO5 |
![GLUCOSAMINE SULFATE SODIUM CHLORIDE](/StructureFile/ChemBookStructure9/GIF/CB7180734.gif) |
GLUCOSAMINE SULFATE SODIUM CHLORIDE |
1296149-13-7 |
C6H15ClNNaO9S |
![N-isopropyltropinium](/CAS/GIF/58005-18-8.gif) |
N-isopropyltropinium |
58005-18-8 |
C11H22BrNO |
![(9Z,12Z)-octadeca-9,12-dienoic acid, monoester with glycerol](/CAS/GIF/26545-74-4.gif) |
(9Z,12Z)-octadeca-9,12-dienoic acid, monoester with glycerol |
26545-74-4 |
C21H38O4 |
![(R)-2-(2-OXO-PYRROLIDIN-1-YL)-BUTYRAMIDE](/CAS/GIF/103765-01-1.gif) |
(R)-2-(2-OXO-PYRROLIDIN-1-YL)-BUTYRAMIDE |
103765-01-1 |
C8H14N2O2 |
![(endo,anti)-(±)-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octane bromide](/CAS/20210111/GIF/58073-59-9.gif) |
(endo,anti)-(±)-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octane bromide |
58073-59-9 |
C20H30BrNO3 |
![cis-Atovaquone](/CAS/GIF/137732-39-9.gif) |
cis-Atovaquone |
137732-39-9 |
C22H19ClO3 |
![Trimethoprim Related Compound B (25 mg) (2,4-diaminopyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanone) (AS)](/CAS/20150408/GIF/30806-86-1.gif) |
Trimethoprim Related Compound B (25 mg) (2,4-diaminopyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanone) (AS) |
30806-86-1 |
C14H16N4O4 |
![둘록세틴불순물A](/CAS/20150408/GIF/947686-09-1.gif) |
둘록세틴불순물A |
947686-09-1 |
C25H23NO3S |
![Citalopram Related Compound H (25 mg) (1-(4'-fluorophenyl)-1-(3-dimethylaminopropyl)-5-bromophthalane hydrobromide)](/CAS/20180808/GIF/479065-02-6.gif) |
Citalopram Related Compound H (25 mg) (1-(4'-fluorophenyl)-1-(3-dimethylaminopropyl)-5-bromophthalane hydrobromide) |
479065-02-6 |
C19H22Br2FNO |
![Fosinopril Related Compound C](/) |
Fosinopril Related Compound C |
|
|
![Labetalol IMpurity A](/CAS/20150408/GIF/1391051-99-2.gif) |
Labetalol IMpurity A |
1391051-99-2 |
C19H23NO4 |
![Levomepromazine hydrochloride](/CAS/GIF/1236-99-3.gif) |
Levomepromazine hydrochloride |
1236-99-3 |
C19H24N2OS.ClH |
![Citalopram Related Compound E](/) |
Citalopram Related Compound E |
|
|
![Loratadine EP IMpurity F](/CAS/20150408/GIF/125743-80-8.gif) |
Loratadine EP IMpurity F |
125743-80-8 |
C22H24ClFN2O2 |
![INSULIN LISPRO (5.97 MG)](/CAS/20180808/GIF/133107-64-9.gif) |
INSULIN LISPRO (5.97 MG) |
133107-64-9 |
C257H383N65O77S6 |
![TRAMADOL IMPURITY E](/StructureFile/ChemBookStructure22/GIF/CB1588123.gif) |
TRAMADOL IMPURITY E |
|
C16H25NO2 |
![FLUCONAZOLE IMPURITY B](/StructureFile/ChemBookStructure22/GIF/CB1588406.gif) |
FLUCONAZOLE IMPURITY B |
|
C13H12F2N6O |
![옥시클로르프로마진](/CAS/GIF/969-99-3.gif) |
옥시클로르프로마진 |
969-99-3 |
C17H19ClN2OS |
![Fosinopril Related Compound B](/) |
Fosinopril Related Compound B |
|
|
![4-Nitro-2-phenoxyaniline](/CAS/GIF/5422-92-4.gif) |
4-Nitro-2-phenoxyaniline |
5422-92-4 |
C12H10N2O3 |
![Fosinopril Related Compound D](/CAS/20211123/GIF/1356353-41-7.gif) |
Fosinopril Related Compound D |
1356353-41-7 |
C30H47NNaO7P |
![Proguanil Related Compound C (25 mg) (1,5-bis(4-chlorophenyl)biguanide hydrochloride)](/CAS/20180808/GIF/13590-98-2.gif) |
Proguanil Related Compound C (25 mg) (1,5-bis(4-chlorophenyl)biguanide hydrochloride) |
13590-98-2 |
C14H14Cl3N5 |
![[2S-[1[R*(R*)],2α,3aβ,6aβ]]-1-[2-[[3-Cyclohexyl-1-(ethoxycarbonyl)propyl]aMino]-1-oxoprop](/CAS/20150408/GIF/99742-35-5.gif) |
[2S-[1[R*(R*)],2α,3aβ,6aβ]]-1-[2-[[3-Cyclohexyl-1-(ethoxycarbonyl)propyl]aMino]-1-oxoprop |
99742-35-5 |
C23H38N2O5 |
![Ticabesone Propionate](/CAS/GIF/73205-13-7.gif) |
Ticabesone Propionate |
73205-13-7 |
C25H32F2O5S |
![OXALIPLATIN IMPURITY B](/) |
OXALIPLATIN IMPURITY B |
|
|
![PYRANTEL IMPURITY A](/CAS/20200611/GIF/36700-38-6.gif) |
PYRANTEL IMPURITY A |
36700-38-6 |
C11H14N2S |
![N-Succinyl-L-tyrosine](/CAS/GIF/374816-32-7.gif) |
N-Succinyl-L-tyrosine |
374816-32-7 |
C13H15NO6 |
![rac N-Desisopropyl-N-ethyl Acebutolol](/CAS/GIF/441019-91-6.gif) |
rac N-Desisopropyl-N-ethyl Acebutolol |
441019-91-6 |
C17H26N2O4 |
![프로파페논관련화합물B(50mg)((2E)-1-[2-[(2RS)-2-하이드록시-3-(프로필아미노)프로폭시]페닐]-3-페닐프로프-2-엔-1-온)](/CAS/20180808/GIF/88308-22-9.gif) |
프로파페논관련화합물B(50mg)((2E)-1-[2-[(2RS)-2-하이드록시-3-(프로필아미노)프로폭시]페닐]-3-페닐프로프-2-엔-1-온) |
88308-22-9 |
C21H25NO3 |
![2-[(1,1-DIMETHYLETHYL) AMINO]-1-[4-OH-3-(HYDROXYMETHYL)PHENYL]ETHAN-1-ONE](/CAS/GIF/156547-62-5.gif) |
2-[(1,1-DIMETHYLETHYL) AMINO]-1-[4-OH-3-(HYDROXYMETHYL)PHENYL]ETHAN-1-ONE |
156547-62-5 |
C13H19NO3 |
![INSULIN ASPART](/) |
INSULIN ASPART |
116094-23-6 |
C256H381N65O79S6 |
![1-(3,4-dihydroxyphenyl)-2-[(1-methylethyl)amino] hydrochloride](/CAS/GIF/16899-81-3.gif) |
1-(3,4-dihydroxyphenyl)-2-[(1-methylethyl)amino] hydrochloride |
16899-81-3 |
C11H15NO3.ClH |
![Talampicillin hydrochloride](/CAS/GIF/39878-70-1.gif) |
Talampicillin hydrochloride |
39878-70-1 |
C24H23N3O6S.ClH |
![4H-IMIDAZO[1,5-A][1,4]BENZODIAZEPINE-3-CARBOXYLIC ACID, 8-FLUORO-5,6-DIHYDRO-5-METHYL-6-OXO-](/CAS/GIF/84378-44-9.gif) |
4H-IMIDAZO[1,5-A][1,4]BENZODIAZEPINE-3-CARBOXYLIC ACID, 8-FLUORO-5,6-DIHYDRO-5-METHYL-6-OXO- |
84378-44-9 |
C13H10FN3O3 |
![DIAZEPAM RELATED COMPOUND B (25 MG) (3-AMINO-6-CHLORO-1-METHYL-4-PHENYLCARBOSTYRIL)](/CAS/GIF/5220-02-0.gif) |
DIAZEPAM RELATED COMPOUND B (25 MG) (3-AMINO-6-CHLORO-1-METHYL-4-PHENYLCARBOSTYRIL) |
5220-02-0 |
C16H13ClN2O |
![10-Formylfolic Acid](/CAS/GIF/134-05-4.gif) |
10-Formylfolic Acid |
134-05-4 |
C20H19N7O7 |
![Fosinopril Related Compound E](/) |
Fosinopril Related Compound E |
|
|
![(±)-N-[3-acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]acetamide](/CAS/GIF/22568-64-5.gif) |
(±)-N-[3-acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]acetamide |
22568-64-5 |
C16H24N2O4 |
![alpha-Methyl-4-biphenylacetic acid](/CAS/GIF/6341-72-6.gif) |
alpha-Methyl-4-biphenylacetic acid |
6341-72-6 |
C15H14O2 |
![Zinc acexamate](/CAS/GIF/70020-71-2.gif) |
Zinc acexamate |
70020-71-2 |
C16H28N2O6Zn |
![INDINAVIR (100 MG)F0D3080.971MG/MG(AI)](/CAS/20180808/GIF/180683-37-8.gif) |
INDINAVIR (100 MG)F0D3080.971MG/MG(AI) |
180683-37-8 |
C36H49N5O5 |
![BUPIVACAINE IMPURITY E](/) |
BUPIVACAINE IMPURITY E |
|
|
![FENTICONAZOLE IMPURITY D](/) |
FENTICONAZOLE IMPURITY D |
|
|
![CEFACLOR, DELTA-3-ISOMER (30 MG)](/CAS/20200611/GIF/152575-13-8.gif) |
CEFACLOR, DELTA-3-ISOMER (30 MG) |
152575-13-8 |
C15H14ClN3O4S |
![(2S)-1-[2-Methylpropanoyl]-pyrrolidine-2-carboxylic Acid](/CAS/20130318/GIF/CB92605022.gif) |
(2S)-1-[2-Methylpropanoyl]-pyrrolidine-2-carboxylic Acid |
23500-15-4 |
C9H15NO3 |
![ERYTHROMYCIN B](/CAS/GIF/527-75-3.gif) |
ERYTHROMYCIN B |
527-75-3 |
C37H67NO12 |
![citreoviridin](/CAS/GIF/25425-12-1.gif) |
citreoviridin |
25425-12-1 |
C23H30O6 |
![DULCOSIDEA](/CAS/GIF/64432-06-0.gif) |
DULCOSIDEA |
64432-06-0 |
C38H60O17 |
![NNK-d3, 4-(Methyl-d3-nitrosoamino)-1-(3-pyridinyl)-1-butanone](/CAS/GIF/86270-92-0.gif) |
NNK-d3, 4-(Methyl-d3-nitrosoamino)-1-(3-pyridinyl)-1-butanone |
86270-92-0 |
C10H10D3N3O2 |
![Cetirizine Ethyl Ester (USP RC A)](/CAS/20150408/GIF/246870-46-2.gif) |
Cetirizine Ethyl Ester (USP RC A) |
246870-46-2 |
C23H29ClN2O3 |
![MONONONADECANOIN](/StructureFile/ChemBookStructure3/GIF/CB0481249.gif) |
MONONONADECANOIN |
112340-30-4 |
C22H44O4 |
![LEVOCARNITINE RELATED COMPOUND A (100 MG) (3-CARBOXY-N,N,N-TRIMETHYL-2-PROPEN-1-AMINIUM CHLORIDE)](/CAS/GIF/6538-82-5.gif) |
LEVOCARNITINE RELATED COMPOUND A (100 MG) (3-CARBOXY-N,N,N-TRIMETHYL-2-PROPEN-1-AMINIUM CHLORIDE) |
6538-82-5 |
C7H13ClNO2 |
![T-2 TRIOL](/CAS/GIF/34114-98-2.gif) |
T-2 TRIOL |
34114-98-2 |
C20H30O7 |
![2-PENTYL BUTYRATE](/CAS/GIF/60415-61-4.gif) |
2-PENTYL BUTYRATE |
60415-61-4 |
C9H18O2 |
![1-Cyano-3-isopropylguanidine](/CAS2/GIF/44830-55-9.gif) |
1-Cyano-3-isopropylguanidine |
44830-55-9 |
C5H10N4 |
![LevetiracetaM IMpurity B](/CAS/20180808/GIF/358629-47-7.gif) |
LevetiracetaM IMpurity B |
358629-47-7 |
C8H12N2O2 |
![2,2-BIS[4-(3-CHLORO-2-HYDROXYPROPOXY)PHENYL]PROPANE](/CAS/GIF/4809-35-2.gif) |
2,2-BIS[4-(3-CHLORO-2-HYDROXYPROPOXY)PHENYL]PROPANE |
4809-35-2 |
C21H26Cl2O4 |
![CYLINDROSPERMOPSIN](/CAS/GIF/143545-90-8.gif) |
CYLINDROSPERMOPSIN |
143545-90-8 |
C15H21N5O7S |
![bis(8-methylnonyl) phthalate](/CAS/GIF/89-16-7.gif) |
bis(8-methylnonyl) phthalate |
89-16-7 |
C28H46O4 |
![4'-(pyrimidin-2-ylsulphamoyl)acetanilide](/CAS/GIF/127-74-2.gif) |
4'-(pyrimidin-2-ylsulphamoyl)acetanilide |
127-74-2 |
C12H12N4O3S |
![KAFFEESA URE-1,1-DIMETHYLALLYLESTER >95% (HPLC)](/CAS/GIF/118971-61-2.gif) |
KAFFEESA URE-1,1-DIMETHYLALLYLESTER >95% (HPLC) |
118971-61-2 |
C14H16O4 |
![WHEAT FLOUR](/) |
WHEAT FLOUR |
|
|
![estra-1,3,5(10)-triene-3,17beta-diol 17-butyrate](/CAS/GIF/18069-79-9.gif) |
estra-1,3,5(10)-triene-3,17beta-diol 17-butyrate |
18069-79-9 |
C22H30O3 |
![3-RINGNOGE(NOVOLACGLYCIDYLETHER)MIXTUREOFISOMERS](/) |
3-RINGNOGE(NOVOLACGLYCIDYLETHER)MIXTUREOFISOMERS |
158163-01-0 |
|
![[3-[2-(diMethylaMino)ethyl]-2-[[3-[2-(diMethylaMino)ethyl]-1H-indol-5-yl]Methyl]-1H-indol-5-yl]-N-MethylMethanesulfonaMide, succinate salt](/CAS/GIF/545338-89-4.gif) |
[3-[2-(diMethylaMino)ethyl]-2-[[3-[2-(diMethylaMino)ethyl]-1H-indol-5-yl]Methyl]-1H-indol-5-yl]-N-MethylMethanesulfonaMide, succinate salt |
545338-89-4 |
C27H37N5O2S |
![Meta-Fexofenadine](/CAS/GIF/479035-75-1.gif) |
Meta-Fexofenadine |
479035-75-1 |
C32H39NO4 |
![BISPHENOL A (3-CHLORO-2-HYDROXYPROPYL) G](/CAS/GIF/13836-48-1.gif) |
BISPHENOL A (3-CHLORO-2-HYDROXYPROPYL) G |
13836-48-1 |
C21H25ClO4 |
![BUPIVACAINE IMPURITY B](/) |
BUPIVACAINE IMPURITY B |
|
|
![3-(3,5-DIHYDROXYPHENYL)-1-PROPANOICACID](/CAS/GIF/26539-01-5.gif) |
3-(3,5-DIHYDROXYPHENYL)-1-PROPANOICACID |
26539-01-5 |
C9H10O4 |
![MILK POWDER](/) |
MILK POWDER |
|
|
![Platinum, (1,2-cyclohexanediamine-N,N')dinitrato-,(sp-4-2, 1R-trans)-](/CAS/20211123/GIF/66900-68-3.gif) |
Platinum, (1,2-cyclohexanediamine-N,N')dinitrato-,(sp-4-2, 1R-trans)- |
66900-68-3 |
C6H12N4O6Pt |
![Lisinopril Cyclohexyl Analog](/CAS/20150408/GIF/1132650-67-9.gif) |
Lisinopril Cyclohexyl Analog |
1132650-67-9 |
C21H37N3O5 |
![MelaMine-13C3](/CAS/20130318/GIF/CB62646363.gif) |
MelaMine-13C3 |
1173022-88-2 |
C3H6N6 |
![BISPHENOL A (2 3-DIHYDROXYPROPYL) GLYCID](/CAS/GIF/76002-91-0.gif) |
BISPHENOL A (2 3-DIHYDROXYPROPYL) GLYCID |
76002-91-0 |
C21H26O5 |
![옥수수씨가루](/) |
옥수수씨가루 |
68525-86-0 |
|
![PEANUT MEAL](/) |
PEANUT MEAL |
|
|
![2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha)]-](/CAS/GIF/41411-66-9.gif) |
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha)]- |
41411-66-9 |
C22H25ClN2O8 |
![7-OXO-11-DODECENOIC ACID](/CAS/GIF/54921-60-7.gif) |
7-OXO-11-DODECENOIC ACID |
54921-60-7 |
C12H20O3 |
![Flavoxate Related Compound C (20 mg) (3-Methylflavone-8-carboxylic acid ethyl ester)](/CAS/20180808/GIF/35888-94-9.gif) |
Flavoxate Related Compound C (20 mg) (3-Methylflavone-8-carboxylic acid ethyl ester) |
35888-94-9 |
C19H16O4 |
![달라세트론(메실레이트수화물)](/CAS/20210111/GIF/878143-33-0.gif) |
달라세트론(메실레이트수화물) |
878143-33-0 |
C20H24N2O6S |
![OCIMENE QUINTOXIDE](/CAS/GIF/7416-35-5.gif) |
OCIMENE QUINTOXIDE |
7416-35-5 |
C10H18O |
![T-2 TETRAOL](/CAS/GIF/34114-99-3.gif) |
T-2 TETRAOL |
34114-99-3 |
C15H22O6 |
![1,3-DIHYDROXY-5-NONADECYLBENZEN](/CAS/GIF/35176-46-6.gif) |
1,3-DIHYDROXY-5-NONADECYLBENZEN |
35176-46-6 |
C25H44O2 |
![Olopatadine N-Oxide](/CAS/GIF/203188-31-2.gif) |
Olopatadine N-Oxide |
203188-31-2 |
C21H23NO4 |
![HYOSCINE BUTYLBROMIDE IMPURITY E](/) |
HYOSCINE BUTYLBROMIDE IMPURITY E |
|
|
![MALACHITE GREEN D5 PICRATE](/StructureFile/ChemBookStructure22/GIF/CB8634799.gif) |
MALACHITE GREEN D5 PICRATE |
1258668-21-1 |
C29H22D5N5O7 |
![D-Phenylalanine, N-[[4-(1-methylethyl)cyclohexyl]carbonyl]-, cis-](/CAS/GIF/105816-06-6.gif) |
D-Phenylalanine, N-[[4-(1-methylethyl)cyclohexyl]carbonyl]-, cis- |
105816-06-6 |
C19H27NO3 |
![2,6-DIHYDROXY-4-METHYLBENZALDEHYDE](/CAS/GIF/526-37-4.gif) |
2,6-DIHYDROXY-4-METHYLBENZALDEHYDE |
526-37-4 |
C8H8O3 |
![BISPHENOL A-(3-CHLORO-2-HYDROXYPROPYL)-&](/CAS/GIF/227947-06-0.gif) |
BISPHENOL A-(3-CHLORO-2-HYDROXYPROPYL)-& |
227947-06-0 |
C21H27ClO5 |
![WARFARIN RELATED COMPOUND A (50 MG) (3-(O-HYDROXYPHENYL)-5-PHENYL-2-CYCLOHEXEN-1-ONE)](/) |
WARFARIN RELATED COMPOUND A (50 MG) (3-(O-HYDROXYPHENYL)-5-PHENYL-2-CYCLOHEXEN-1-ONE) |
37209-23-7 |
|
![REBAUDIOSIDE B(P)(NEW)](/CAS/GIF/58543-17-2.gif) |
REBAUDIOSIDE B(P)(NEW) |
58543-17-2 |
C38H60O18 |
![OXALIPLATIN IMPURITY D](/) |
OXALIPLATIN IMPURITY D |
|
|